-
NewCap is chosen as the new investor relations firm for BIOGENERA Posted on by adminbio in Corporate Update
-
BIOGENERA participated in the International Congress on Neuroblastoma ANR (Advances in Neuroblastoma Research) held in Amsterdam May 15-18, 2023 Posted on by adminbio in Event
-
Thibaud Eckenschwiller has been appointed president of BIOGENERA, May 2023 Posted on by adminbio in Corporate Update
-
Giacinto d’Ettorre becomes board member of BIOGENERA Posted on by adminbio in Corporate Update
-
Patent Approval in Argentina Posted on by adminbio in Search
-
The company ComputerShare has been chosen to manage the corporate structure of BIOGENERA. Posted on by adminbio in Corporate Update
-
BIOGENERA has reached a new milestone in lung cancer treatment Posted on by adminbio in Search
-
MYCN is a key target for cases of High-Risk Neuroblastoma Posted on by adminbio in Search
-
Oligonucleotides represent a new frontier for expanding drug targets for targeted cancer treatment Posted on by adminbio in Search
-
New drug BGA002 overcomes Neuroblastoma resistance to Retinoic Acid drug Posted on by adminbio in Search
-
BIOGENERA chooses Gitti & Partners as legal advisor Posted on by adminbio in Corporate Update